Header cover image
  • Investing Ideas
  • Malaysian Pharmaceuticals & Biotech Undervalued over 20% based on DCF

Malaysian Pharmaceuticals & Biotech Undervalued over 20% based on DCF

Results

1

0 new

Companies which are undervalued more than 20% based on the Discounted Cash Flow valuation.

1 companies

Duopharma Biotech Berhad

Market Cap: RM 1.3b

An investment holding company, researches, develops, manufactures, distributes, and imports pharmaceutical products and medicines in Malaysia and internationally.

DPHARMA

RM 1.32

7D

3.1%

1Y

13.8%